[1]Frank RN. Diabetic retinopathy[J]. N Engl J Med, 2004, 350(1): 48-58. [2]Gariano RF, Gardner TW. Retinal angiogenesis in development and disease[J]. Nature,2005,438(7070):960-6. [3]Martin PM, Roon P, Van Ells TK, et al. Death of retinal neurons in streptozotocin-induced diabetic mice[J]. Invest Ophthalmol Vis Sci, 2004,45(9):3330-6. [4]Nakagawa T, Sato W, Glushakova O, et al. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy[J]. J Am Soc Nephrol,2007,18(2):539-50. [5]Zhao HJ, Wang S, Cheng H, et al. Endothelial nitric oxide synthase deficiency produces accelerated nephropathy in diabetic mice[J]. J Am Soc Nephrol,2006,17(10):2664-9. [6]Lei B, Yao G, Zhang K, et al. Study of rod- and cone-driven oscillatory potentials in mice[J]. Invest Ophthalmol Vis Sci, 2006, 47(6):2732-8. [7]Layton CJ, Safa R, Osborne NN. Oscillatory potentials and the b-wave: partial masking and interdependence in dark adaptation and diabetes in the rat[J]. Graefes Arch Clin Exp Ophthalmol, 2007,245(9):1335-45. [8]Li Q, Zemel E, Miller B, et al. Early retinal damage in experimental diabetes: electroretinographical and morphological observations[J]. Exp Eye Res,2002,74(5):615-25. [9]Neckell A. Adaptometry in diabetic patients[J]. Oftalmologia,2007, 51 (3):95-7. [10]Awata T, Neda T, Iizuka H, et al. Endothelial nitric oxide synthase gene is associated with diabetic macular edema in type2diabetes [J]. Diabetes Care,2004,27(9):2184-90. [11]Ezzidi I, Mtiraoui N, Mohamed MB, et al. Endothelial nitric oxide synthase Glu298Asp,4b/a, and T-786C polymorphisms in type2 diabetic retinopathy[J]. Clin Endocrinol (Oxf),2008,68(4):542-6. [12]Chen Y, Huang H, Zhou J, et al. Polymorphism of the endothelial nitric oxide synthase gene is associated with diabetic retinopathy in a cohort of West Africans[J]. Mol Vis,2007,13:2142-7. [13]Durante W, Sen AK, Sunahara FA. Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats[J]. Br J Pharmacol,1988,94(2):463-8. [14]Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus[J]. J Am Coll Cardiol,1996,27(3):567-74. [15]Dawson VL, Dawson TM. Nitric oxide neurotoxicity[J]. J Chem Neuroanat,1996,10(3-4):179-90. [16]Al-Shabrawey M, El-Remessy A, Gu X, et al. Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase [J]. Mol Vis,2003,9:549-58. [17]Liu VW, Huang PL. Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice[J]. Cardiovasc Res,2008,77(1):19-29. [18]Barber AJ, Gardner TW, Abcouwer SF. The significance of vascular and neural apoptosis to the pathology of diabetic retinopathy[J]. Invest Ophthalmol Vis Sci,2011,52(2):1156-63. [19]Ozawa Y, Kurihara T, Sasaki M, et al. Neural degeneration in the retina of the streptozotocin-induced type 1diabetes model[J]. Exp Diabetes Res,2011,2011:108328 |